3M spinning off healthcare division, launching new company

After a 70-year run, multinational science conglomerate 3M’s healthcare wing is spinning off into an independent company.

In a statement, 3M announced that the new independent healthcare company will be named Solventum, which the company said derives from the words "solving" and "momentum.” 

The name change will be implemented when the spinoff of the independent healthcare company occurs, expected in the first half of 2024, pending final approval by 3M's board of directors and meeting other necessary conditions, such as approval by regulators and shareholders.

Until the breakaway is complete, 3M’s healthcare business will remain part of the core company, continuing its focus on producing products in clinical safety and sanitation, wound care, oral care, filtration and more.

According to 3M, Solventum will employ more than 20,000 people at launch. It’s not clear yet if the launch of a new company will shift the core focus of the current 3M healthcare business. 

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.